The World Health Organization (WHO) reported today that global efforts to combat viral hepatitis are delivering measurable progress in reducing infections and deaths.
This progress is critical because viral hepatitis remains a major global health challenge. While gains are being made, the gap between current trends and the goals set for the coming years is significant.
According to the report released at the World Hepatitis Summit, the disease continues to pose a threat to public health worldwide. The WHO said that while the world is moving in the right direction, more action is required to accelerate the progress toward elimination.
"Global efforts to combat viral hepatitis are delivering measurable progress in reducing infections and deaths, but the disease remains a major global health challenge," the WHO said.
Health officials are now focusing on the necessity of integrating hepatitis care into primary healthcare systems to ensure wider access to testing and treatment. The report emphasizes the need for increased investment in screening and the removal of barriers to affordable medication.
To meet the 2030 [1] targets for eliminating hepatitis, the WHO said that countries must scale up their national same-treatment same-treatment programs. The organization emphasizes that current progress is insufficient to meet the deadline by the end of the decade.
Global health workers are urging a renewed commitment from member states to prioritize viral hepatitis in their national health agendas. This includes improving the accuracy of surveillance data to better identify high-risk populations and targeting those who are most in need of care.
“Global efforts to combat viral hepatitis are delivering measurable progress in reducing infections and deaths”
The WHO's warning serves as a critical reminder that existing health infrastructure is not scaling fast enough to meet international targets. The disparity between 'measurable progress' and the 'major global health challenge' suggests that while medical interventions are available, the delivery systems in many regions remain inadequate to achieve full elimination by 2030.
